Trial intelligence / Profile preview

Injection Comfort of NeoRecormon vs Darbepoetin Alfa in Renal Anemia

NCT00377481Phase 4Completed

Sponsor
Roche
Start
Sep 2006
Primary completion
Jun 2007
Modality
Erythropoietins, Colony Stimulating Factors
Countries
1
01

Overview

A Phase 4 trial of epoetin beta in anemia of chronic kidney disease, sponsored by Roche. Started Sep 2006; status: completed.

02

Drugs

epoetin beta
03

Conditions

anemia of chronic kidney disease

Beyond the preview

Go deeper on NCT00377481.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00377481.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call